About this trial
The goal of this clinical trial is to learn whether different ways of providing information and follow-up support after acute kidney injury, also called AKI, can improve care transitions for adults being discharged from the hospital. AKI is a sudden decrease in kidney function that can occur during a hospital stay.
The main questions this study aims to answer are:
* Does an AKI discharge summary template improve communication about AKI after hospital discharge? * Does a chat-based educational messaging program improve patient understanding of AKI and support follow-up care after hospital discharge? * Researchers will compare usual care, an AKI discharge summary template, a chat-based educational messaging program, and the combination of the discharge summary template plus chat-based messaging.
Researchers will compare four groups:
* Usual care * An AKI discharge summary template * A chat-based educational messaging program * Both the AKI discharge summary template and the chat-based educational messaging program
Participants will complete questionnaires at the start of the study and about 4 weeks after hospital discharge. Participants will also receive a brief phone call about 3 months after discharge, and the research team will review their medical record for information about follow-up care, lab testing, emergency department visits, and hospital readmissions.
Eligibility criteria
Qualifiers
Age 18 years or older
Hospitalized with Stage 2 or Stage 3 acute kidney injury
Kidney function has not returned to baseline at the time of hospital discharge
Able to communicate in English
Disqualifiers
Acute kidney injury requiring ongoing dialysis at the time of hospital discharge
End-stage kidney disease
Kidney transplant recipient
Currently pregnant
Trial design
Treatments tested in this trial
- AKI Discharge Summary Template
- Chat-Based Educational Messaging Program
Treatment groups
Locations
Sponsors and collaborators
Northwell Health
Lead sponsor
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Collaborator